Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4588
Title: | Sialuria: Ninth Patient Described Has a Novel Mutation in GNE | Authors: | Martinez, N. N. Wilcken, B. Robinson, J. Lipke, M. |
Issue Date: | 2019 | Source: | 44 , 2019, p. 17-21 | Pages: | 17-21 | Journal: | JIMD Rep | Abstract: | Sialuria is a rare autosomal dominant inborn error of metabolism characterized by cytoplasmic accumulation and urinary excretion of gram quantities of free sialic acid due to failure of feedback inhibition of the rate-limiting enzyme in the sialic acid synthesis pathway, UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE/MNK). To date, eight cases had been published worldwide, all with heterozygous missense variants at the allosteric site, specifically at Arginine 294 (formerly 263) and Arginine 297 (formerly 266) of GNE. The described cases so far have rather homogeneous clinical features which include developmental delay, mildly coarse features, hepatomegaly and prolonged neonatal jaundice. The apparent rarity of this disorder is hypothesized to be due to the variable and sometimes transient nature of the clinical features and to the absence of routine testing for urinary sialic acids. Here we present the ninth case of sialuria diagnosed in a child investigated because of clinical signs and symptoms and furthermore describe a novel pathogenic variant in the associated gene, GNE.2192-8312Martinez, Noelia Nunez | DOI: | 10.1007/8904_2018_117 | Keywords: | Sialic acids;GneHepatomegaly;Sialuria;UDP acetylglucosamine-2-epimerase | Type: | Article |
Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.